Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial

about

Prediabetes: the importance of early identification and intervention.Angiotensin receptor blockers: pharmacology, efficacy, and safety.Angiotensin II receptor antagonists in acute coronary syndromes.Olmesartan medoxomil-based therapy for the management of hypertension.

P2860

Q37777010-36408510-ABCD-42C2-AAF1-F208A8EE840F Q37928133-65D6206E-8617-493E-937B-B0B3FF293920 Q38167346-0DBFF58E-4D0E-4CB6-B478-6E706585FB5A Q38178325-3D98BC3B-3EC4-4984-ADE2-39232631AF7D

P2860

Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial

Item

http://www.wikidata.org/entity/Q28286410

description

2008 nî lūn-bûn

@nan

2008 թուականին հրատարակուած գիտական յօդուած

@hyw

2008 թվականին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Progressive effects of valsart ...... sive patients: the VALUE trial

@ast

Progressive effects of valsart ...... sive patients: the VALUE trial

@en

Progressive effects of valsart ...... sive patients: the VALUE trial

@nl

type

Item

label

Progressive effects of valsart ...... sive patients: the VALUE trial

@ast

Progressive effects of valsart ...... sive patients: the VALUE trial

@en

Progressive effects of valsart ...... sive patients: the VALUE trial

@nl

prefLabel

Progressive effects of valsart ...... sive patients: the VALUE trial

@ast

Progressive effects of valsart ...... sive patients: the VALUE trial

@en

Progressive effects of valsart ...... sive patients: the VALUE trial

@nl

P1476

Progressive effects of valsart ...... sive patients: the VALUE trial

@en

P2093

Alberto Zanchetti

http://www.w3.org/2001/XMLSchema#string

Antonio Coca

http://www.w3.org/2001/XMLSchema#string

Gordon T McInnes

http://www.w3.org/2001/XMLSchema#string

Jiri Widimsky

http://www.w3.org/2001/XMLSchema#string

Kenneth Jamerson

http://www.w3.org/2001/XMLSchema#string

M Anthony Schork

http://www.w3.org/2001/XMLSchema#string

Michael A Weber

http://www.w3.org/2001/XMLSchema#string

Pierre Larochelle

http://www.w3.org/2001/XMLSchema#string

Reuven Viskoper

http://www.w3.org/2001/XMLSchema#string

Roland E Schmieder

http://www.w3.org/2001/XMLSchema#string

P2860

Global and societal implications of the diabetes epidemic

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Effect of ramipril on the incidence of diabetes.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.

P304

170-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08037050802169644

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Mancia

Thomas Macdonald

Sverre E. Kjeldsen

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18608200

http://www.w3.org/2001/XMLSchema#string

Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial

about

P2860

P2860

Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698